First results of randomised clinical screening trials are traditionally met with a barrage of comments by opinionated observers, and the back-to-back publication in the March 26 issue of the New England Journal of Medicine on [more]
Selected repor ts edited by Janet Fricker Download full article
Hormonal treatment remains a main stay of systemic therapy for prostate cancer despite recent developments in chemotherapy and intensive research with targeted drugs and immunotherapy. Its efficacy in palliative management of advanced disease has prompted [more]
Selected reports edited by Janet Fricker Download full article
Selected reports edited by Janet Fricker Download full article
Selected reports edited by Janet Fricker Download full article
Selected reports edited by Hannah Brown Download full article
Selected reports edited by Hannah Brown Download full article
Selected press reports complied by the ESO Cancer Media Centre Download full article
In prostate cancer, a trial comparing conventional- versus high-dose conformal radiotherapy has shown that increasing the dose can improve outcome, with only slight increases in toxicity. Download full article
Selected press reports compiled by the ESO Cancer Media Centre Download full article
In men with intermediate- to high-risk prostate cancer, radical prostatectomy has been shown to lower the risk of local or systemic progression, and cancer-specific and overall mortality, compared with watchful waiting. Download full article
In recounting their personal stories, cancer patients are not only sharing their experiences and feelings they are providing practical support to others and are gradually influencing the way cancer is perceived and treated. Download [more]